Penserra Capital Management LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 88 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$280
+294.4%
220,8580.0%0.01%
+500.0%
Q2 2023$71
-24.5%
220,858
+0.8%
0.00%
-50.0%
Q1 2023$94
-17.5%
219,146
+1.6%
0.00%
-33.3%
Q4 2022$114
-99.9%
215,722
+1.6%
0.00%
-25.0%
Q3 2022$155,000
-61.1%
212,298
-39.2%
0.00%
-63.6%
Q2 2022$398,000
-44.6%
349,336
-0.5%
0.01%
-35.3%
Q1 2022$719,000
-39.1%
351,154
-14.4%
0.02%
-32.0%
Q4 2021$1,180,000
-26.8%
410,062
+7.7%
0.02%
-24.2%
Q3 2021$1,613,000
-18.1%
380,698
+2.2%
0.03%
-8.3%
Q2 2021$1,969,000
+18.8%
372,384
+4.3%
0.04%
+16.1%
Q1 2021$1,658,000
+290.1%
356,876
+176.1%
0.03%
+210.0%
Q4 2020$425,000
+98.6%
129,252
+98.8%
0.01%
+25.0%
Q3 2020$214,000
-32.9%
65,002
-31.5%
0.01%
-50.0%
Q2 2020$319,000
-5.1%
94,962
+8.0%
0.02%
-30.4%
Q1 2020$336,000
+168.8%
87,942
+250.0%
0.02%
+187.5%
Q4 2019$125,000
-11.3%
25,128
+34.2%
0.01%
-33.3%
Q3 2019$141,00018,7260.01%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 2,679,457$20,257,0000.73%
Portolan Capital Management 777,293$5,876,0000.66%
CAMPBELL CAPITAL MANAGEMENT INC 110,451$835,0000.62%
ZEKE CAPITAL ADVISORS, LLC 402,212$3,041,0000.27%
Leap Investments LP 46,084$348,0000.17%
Bernardo Wealth Planning LLC 26,419$199,0000.14%
Claraphi Advisory Network, LLC 14,744$111,0000.07%
Sterling Investment Advisors, Ltd. 11,000$83,0000.04%
A.R.T. Advisors, LLC 81,372$615,0000.03%
Mirae Asset Global Investments Co., Ltd. 544,408$4,116,0000.03%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders